GLEMBATUMUMAB
UNII WEC7MEM1BR

Substance Identification & Data

This profile provides standardized clinical and technical data for Glembatumumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WEC7MEM1BR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1020264-78-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WEC7MEM1BR

CAS Registry Number

1020264-78-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GLEMBATUMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C84520

National Cancer Institute reference terminology for clinical and research data.

INN ID

9199

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

UU-163

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Glembatumumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GLEMBATUMUMAB

Common Names & Synonyms

GLEMBATUMUMAB [INN]

GLEMBATUMUMAB [USAN]

IMMUNOGLOBULIN, ANTI-(HUMAN GLYCOPROTEIN NMB EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL CR011 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CR011 .GAMMA.2 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN, ANTI-(HUMAN GLYCOPROTEIN NMB EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL CR011 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL CR011 .GAMMA.2 .KAPPA.-CHAIN, DIMER

Technical Codes

CR011

CR-011

External Clinical & Regulatory Resources

Previous UNIIWEC6I2K1FC

Next UNIIWEC9M7UOAG